Gain deep insights into companies, competitors, and market trends to drive smarter business growth and success.

AFFINE FORMULATIONS LIMITED

Active

AFFINE FORMULATIONS LIMITED having CIN U24232MP2006PLC018755 is 18 years , 11 month & 17 days old Public Indian Company incorporated on 04 Jul 2006. It is classified as Non-government company and is registered at ROC Gwalior. Its authorized share capital is Rs. 100,000,000 and its paid up capital is Rs. 60,000,000. It's NIC code is 24232 (which is part of its CIN).

As per the NIC code, it is involved in Manufacture Of Allopathic Pharmaceutical Preparations . AFFINE FORMULATIONS LIMITED Annual General Meeting (AGM) was last held on N/A and as per records from Ministry of Corporate Affairs (MCA), its balance sheet was last filed on 09-30-2022. Directors of AFFINE FORMULATIONS LIMITED are Anil Kumar Jain and Vijay Kumar Nyati.

AFFINE FORMULATIONS LIMITED ' Corporate Identification Number (CIN) is U24232MP2006PLC018755 and its registration number is 018755. Users may contact AFFINE FORMULATIONS LIMITED on its Email address - info@affineformulations.com Registered address of AFFINE FORMULATIONS LIMITED is 28/10 TALWALI DEWAS NAKA,INDORE,Madhya Pradesh,India-452010. Current status of AFFINE FORMULATIONS LIMITED is - Active.

Key Indicators

Authorised Capital
100,000,000

as on 21/06/2025

Paid Up Capital
60,000,000

as on 21/06/2025

Company Age
18 Year, 11 Months
Last Filing with ROC
2 Year, 8 Months

Company Information

CIN U24232MP2006PLC018755
Company Status Active
Registration Number 018755
Date of Incorporation 07/04/2006
RoC ROC Gwalior
Company Age 18 years & 357 days
Authorized Capital ₹ 100000000
Paid-up capital ₹ 60000000
Company Category Company limited by shares
Company Sub-Category Non-government company
Class of company Public
Activity Manufacture Of Allopathic Pharmaceutical Preparations
Listing status Unlisted
Date of Last Annual General Meeting 31-03-2021
Date of Latest Balance Sheet 31-03-2021

Contact

Email ID info@affineformulations.com
Address LASUDIA MORI INDORE Madhya Pradesh India 452001
Website affineformulations.com
Contact Number +91*******

Location on Map

Director

DIN Name Date OF Appointment Designation Tenure
01516050
SHAILENDRA BIYANI
29 Aug 2016 Director 18 years
00362130
VIJAY KUMAR NYATI
16 Jun 2023 Director 18 years
01515970
PRADHYUMN NYATI
29 Aug 2016 Director 18 years
01584143
GAUTAM CHAND DHING
05 Sep 2016 Director 18 years
07600233
AMITA BHUTDA
05 Sep 2016 Director 18 years
08033364
MAHESH JAKHATIA
29 Sep 2018 Director 18 years
05173809
ANIL KUMAR JAIN
24 Nov 2021 Director 18 years

Companies connected through Directors

Name Status Paid Up Capital Common Directors Address
BENSONS HEALTHCARE LIMITED
Strike Off
0.00 1 Madhya Pradesh
TIRUPATI COLONISERS AND BUILDHOMES PRIVATE LIMITED
Strike Off
1,00,000.00 1 Madhya Pradesh

Charges on assets

1

STATE BANK OF INDIA

No. of Loans: 1

Total Amount: 88,100,000.00 cr

2

Axis Bank Limited

No. of Loans: 1

Total Amount: 133,900,000.00 cr

Charge Holder Branch Amount Date of creation Modification Satisfaction Status
STATE BANK OF INDIA SAI ROAD 88,100,000 07 Dec, 2006 07 Apr, 2012 18 Jan, 2019 Closed
Axis Bank Limited Y.N. Road 133,900,000 26 Sep, 2018 08 Feb, 2022 - Open

Registered Details

CIN
U24232MP2006PLC018755
Incorporation
18 years , 11 month
Company Email
info@affineformulations.com
Paid up Capital
₹ 60,000,000
Authorised Capital
₹ 100,000,000
Type
Public Non-government company

* There is the date provided by MCA, but availability for this year is not guaranteed.

-

Industry

Manufacture Of Allopathic Pharmaceutical Preparations

Key Metrics

** All rupee values in INR crores. Based on March 2024 numbers.

Sales arrow 0.00%
₹ 0
EBITDA arrow 0.00%
₹ 0
Net Profit arrow0.00%
₹ 0
Networth arrow0.00%
₹ 0
Borrowings arrow0.00%
₹ 0
Assets arrow0.00%
₹ 0
Gross Margin arrow0.00%
₹ 0
Operating Margin arrow0.00%
₹ 0
Net Profit Margin arrow0.00%
₹ 0
Return on Equity arrow0.00%
₹ 0
ROCE arrow9.29%
₹ 140,987.4
Debt to Equity arrow0.00%
₹ 0

Financial Highlights

** All numbers in INR

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Sales Locked Locked Locked Locked Locked
Operating profit Locked Locked Locked Locked Locked
Net profit Locked Locked Locked Locked Locked
Gross margin Locked Locked Locked Locked Locked
Operating margin Locked Locked Locked Locked Locked
Net margin Locked Locked Locked Locked Locked
Networth Locked Locked Locked Locked Locked
Borrowings Locked Locked Locked Locked Locked
Assets Locked Locked Locked Locked Locked
Debt to equity Locked Locked Locked Locked Locked
Current ratio Locked Locked Locked Locked Locked
ROE Locked Locked Locked Locked Locked
Days payable Locked Locked Locked Locked Locked
WC days Locked Locked Locked Locked Locked
unlock

Subscribe to access detailed insight of companies

subscribe

Balance Sheet

**** All numbers in INR

Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
EQUITY AND LIABILITIES
(1) Shareholders‘ funds + Locked Locked Locked Locked Locked
(a) Share capita Locked Locked Locked Locked Locked
(b) Reserves and surplus Locked Locked Locked Locked Locked
(c) Money received against share warrants Locked Locked Locked Locked Locked
(2) Share application money pending allotment Locked Locked Locked Locked Locked
(3) Non-current liabilities + Locked Locked Locked Locked Locked
(a) Long-term borrowings Locked Locked Locked Locked Locked
(b) Deferred tax liabilities (Net) Locked Locked Locked Locked Locked
(c) Other Long-term liabilities Locked Locked Locked Locked Locked
(d) Long-term provisions Locked Locked Locked Locked Locked
(4) Current liabilities + Locked Locked Locked Locked Locked
(a) Short-term borrowings Locked Locked Locked Locked Locked
(b) Trade payables Locked Locked Locked Locked Locked
(A) total outstanding dues of micro enterprises and small enterprises; and Locked Locked Locked Locked Locked
(B) total outstanding dues of creditors other than micro enterprises and small enterprises. Locked Locked Locked Locked Locked
(c) Other current liabilities Locked Locked Locked Locked Locked
(d) Short-term provisions Locked Locked Locked Locked Locked
Total Locked Locked Locked Locked Locked
ASSETS
Non-current assets + Locked Locked Locked Locked Locked
(a) [Property, Plant and Equipment] Locked Locked Locked Locked Locked
(i) Tangible assets Locked Locked Locked Locked Locked
(ii) Intangible assets Locked Locked Locked Locked Locked
(iii)Capital work-in-progress Locked Locked Locked Locked Locked
(iv) Intangible assets under development Locked Locked Locked Locked Locked
(b) Non-current investments Locked Locked Locked Locked Locked
(c) Deferred tax assets (net) Locked Locked Locked Locked Locked
(d) Long-term loans and advances Locked Locked Locked Locked Locked
(e) Other non-current assets Locked Locked Locked Locked Locked
(2) Current assets + Locked Locked Locked Locked Locked
(a) Current investments Locked Locked Locked Locked Locked
(b) Inventories Locked Locked Locked Locked Locked
(c) Trade receivables Locked Locked Locked Locked Locked
(d) Cash and cash equivalents Locked Locked Locked Locked Locked
(e) Short-term loans and advances Locked Locked Locked Locked Locked
(f) Other current assets Locked Locked Locked Locked Locked
Total assets Locked Locked Locked Locked Locked
EQUITY AND LIABILITIES
(1) Shareholders‘ funds +
(a) Share capital
(b) Reserves and surplus
(c) Money received against share warrants
(2) Share application money pending allotment
(3) Non-current liabilities +
(a) Long-term borrowings
(b) Deferred tax liabilities (Net)
(c) Other Long-term liabilities
(d) Long-term provisions
(4) Current liabilities +
(a) Short-term borrowings
(b) Trade payables
(A) total outstanding dues of micro enterprises and small enterprises; and
(B) total outstanding dues of creditors other than micro enterprises and small enterprises.
(c) Other current liabilities
(d) Short-term provisions
Total
ASSETS
Non-current assets +
(a) [Property, Plant and Equipment]
(i) Tangible assets
(ii) Intangible assets
(iii)Capital work-in-progress
(iv) Intangible assets under development
(b) Non-current investments
(c) Deferred tax assets (net)
(d) Long-term loans and advances
(e) Other non-current assets
(2) Current assets +
(a) Current investments
(b) Inventories
(c) Trade receivables
(d) Cash and cash equivalents
(e) Short-term loans and advances
(f) Other current assets
Total assets

Profit & Loss

**** All numbers in INR

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
I.Revenue from operations lock lock lock lock lock
II. Other income lock lock lock lock lock
III.Total Revenue (I + II) lock lock lock lock lock
IV.Expenses + lock lock lock lock lock
(1)Cost of materials consumed lock lock lock lock lock
(2)Purchases of Stock-in-Trade lock lock lock lock lock
(3)Changes in inventories of finished goods work-in-progress and lock lock lock lock lock
(4)Stock-in-Trade lock lock lock lock lock
(5)Employee benefits expense lock lock lock lock lock
(6)Finance costs lock lock lock lock lock
(7)Depreciation and amortisation expense lock lock lock lock lock
(8)Other expenses lock lock lock lock lock
(9)Total expenses lock lock lock lock lock
VProfit before exceptional and extraordinary items and tax (III - IV) lock lock lock lock lock
VIExceptional items lock lock lock lock lock
VII.Profit before extraordinary items and tax (V - VI) lock lock lock lock lock
VIII.Extraordinary items lock lock lock lock lock
IX.Profit before tax (VII- VIII) lock lock lock lock lock
X. Tax expense: + lock lock lock lock lock
(1)Current tax lock lock lock lock lock
(2)Deferred tax lock lock lock lock lock
XI.Profit (Loss) for the period from continuing operations (VII-VIII) lock lock lock lock lock
XII.Profit/(loss) from discontinuing operations lock lock lock lock lock
XIII.Tax expense of discontinuing operations lock lock lock lock lock
XIV.Profit/(loss) from Discontinuing operations (after tax) (XII-XIII) lock lock lock lock lock
XV.Profit (Loss) for the period (XI + XIV) lock lock lock lock lock
XVI.Earnings per equity share: + lock lock lock lock lock
(1) Basic lock lock lock lock lock
(2)Diluted lock lock lock lock lock
Precentage of total incomex
unlock

Subscribe to access detailed insight of companies

subscribe

Ratio

** All numbers in INR

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Solvency 0.00 0.00 0.00 0.00 0.00
Total Debt/Equity 0.00 0.00 0.00 0.00 0.00
Total Debt/Assets 0.00 0.00 0.00 0.00 0.00
Total Assets/Equity 0.00 0.00 0.00 0.00 0.00
Liquidity 0.00 0.00 0.00 0.00 0.00
Current Ratio 0.00 0.00 0.00 0.00 0.00
Quick Ratio 0.00 0.00 0.00 0.00 0.00
Interest Coverage 0.00 0.00 0.00 0.00 0.00
Performance 0.00 0.00 0.00 0.00 0.00
Gross Margin 0.00 0.00 0.00 0.00 0.00
Operating Margin 0.00 0.00 0.00 0.00 0.00
Net Margin 0.00 0.00 0.00 0.00 0.00
Return 0.00 0.00 0.00 0.00 0.00
Return on Equity 0.00 0.00 0.00 0.00 0.00
Pre-tax ROCE 0.00 0.00 0.00 0.00 0.00
Return on Assets 0.00 0.00 0.00 0.00 0.00
Pre-tax ROIC 0.00 0.00 0.00 0.00 0.00
Efficiency 0.00 0.00 0.00 0.00 0.00
Days Payable 0.00 0.00 0.00 0.00 0.00
Days Inventory 0.00 0.00 0.00 0.00 0.00
Days Receivable 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover 0.00 0.00 0.00 0.00 0.00
Total Asset Turnover 0.00 0.00 0.00 0.00 0.00
Working Capital 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle 0.00 0.00 0.00 0.00 0.00
Working Capital Days 0.00 0.00 0.00 0.00 0.00
unlock

Subscribe to access detailed insight of companies

subscribe

Subsidiaries, Associate Companies & Join Ventures of Affine Formulations Limited

Company Identifier Name Percentage of Shares Held
lock lock lock
lock lock lock
lock lock lock

Fund Raising Activity of Affine Formulations Limited

Date of Allotment Securities Alloted Terms Number of Securities Nominal Amount Premium Amount Due & Payable Premium Amount Paid Total Discount Amount to be Paid on Calls (Excluding Premium) Attachments
lock lock lock lock lock lock lock lock lock lock
lock lock lock lock lock lock lock lock lock lock
lock lock lock lock lock lock lock lock lock lock

Board Meetings of Affine Formulations Limited

Date of Filing Date of Dispatch of Notice Date of Passing Resolution Section (Companies Act 2013) Purpose of passing the resolution Subject Matter of Resolution Resolution Agreed By Special Resolution Address

Auditors of Affine Formulations Limited

Financial Year Name of Auditor or Firm PAN of Auditor or Firm Membership Number Registration Number Address

Outstanding Payments to Micro & Small Enterprises

Filing Type As On Amount Due to MSME Current Liabilities Ratio to Current Liabilities Reasons for Delay
lock lock lock lock lock lock
lock lock lock lock lock lock
lock lock lock lock lock lock

Investor Complaints & Serious Complaints About Affine Formulations Limited

Director Complain

Date DIN Cessation Date Cessation Reason Complaint
lock lock lock lock lock
lock lock lock lock lock
lock lock lock lock lock

Serious Complaints

Date Complaint Other
lock lock lock
lock lock lock
lock lock lock

Investor Complaints & Other Complaints

Date Complaint Type Complaint Sub Type Particulars of Secutiries Period Complaint Other Details
lock lock lock lock lock lock lock
lock lock lock lock lock lock lock
lock lock lock lock lock lock lock

Prosecution Details of Affine Formulations Limited

S.No. Defaulting Entities Court Name Prosecution Section Date of Order Status
lock lock lock lock lock lock
lock lock lock lock lock lock
lock lock lock lock lock lock

FAQs- Affine Formulations Limited

What is AFFINE FORMULATIONS LIMITED ?

AFFINE FORMULATIONS LIMITED having CIN U24232MP2006PLC018755 is 18 years , 11 month old Public Indian Company incorporated with MCA on 24 Nov 2021. AFFINE FORMULATIONS LIMITED is listed in the class of Public Indian Company and classified as Non-government company. This company is registered at Registrar of Companies(ROC), ROC Gwalior with an Authorized Share Capital of 100,000,000 and paid-up capital is 60,000,000.

What is the CIN of AFFINE FORMULATIONS LIMITED?

CIN of AFFINE FORMULATIONS LIMITED is U24232MP2006PLC018755.

Where is AFFINE FORMULATIONS LIMITED located?

Address of AFFINE FORMULATIONS LIMITED is 28/10 talwali dewas naka,indore,madhya pradesh,india-452010,.

Who are the directors of AFFINE FORMULATIONS LIMITED ?

The company has 8 directors/key management personnel Shailendra Biyani,vijay Nyati,pradhyumn Nyati,gautam Dhing,amita Bhutda,mahesh Jakhatia,anil Jain,vijay Nyati,

What is the contact details of AFFINE FORMULATIONS LIMITED ?

Email : info@affineformulations.com
Address : LASUDIA MORI INDORE Madhya Pradesh India 452001

What does AFFINE FORMULATIONS LIMITED do?

AFFINE FORMULATIONS LIMITED is involved in activities such as Computer programming, consultancy and related activities

Popular Services

Spice Board registration APEDA Registration Importer Exporter Code Registration AD Code Registration ESI Registration FSSAI Registration FCRA Registration FCRA Registration for Trusts FCRA Registration for Societies FCRA Registration for Section 8 Company Import Export Code Import Export Code Process NSIC Registration Private Limited Company Limited Liability Partnership Partnership Firm One Person Company Startup India Registration PF Registration Director KYC Auditor's Appointment Director's Appointment Net worth Certificate Labour License LLP Annual Compliance Filing

Popular Search

Top Companies in your State

Enquiry